The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer.
Authors
Bertucci F, Finetti P, Simeone I, Hendrickx W, Wang E, Marincola FM, Viens P, Mamessier E, Ceccarelli M, Birnbaum D, Bedognetti D
Summary
The immunologic constant of rejection (ICR) is a broad phenomenon of Th-1 immunity-mediated, tissue-specific destruction.
Read the article